DNA-encoded chemical libraries of macrocycles

Current Opinion in Chemical Biology

Volumn 26, Issue , 2015, Pages 42-47

  Connors, William H ^a   Hale, Stephen P ^a   Terrett, Nicholas K ^a  

^a Ensemble Therapeutics Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROCYCLIC COMPOUND; CYCLOPEPTIDE; INSULINASE; MOLECULAR LIBRARY; PEPTIDOMIMETIC AGENT;

APOPTOSIS; CYCLIZATION; DNA LIBRARY; DNA SYNTHESIS; GENETIC CODE; HIGH THROUGHPUT SCREENING; HUMAN; MEMBRANE PERMEABILITY; NEXT GENERATION SEQUENCING; NONHUMAN; PHARMACOPHORE; PROTEIN PROTEIN INTERACTION; REVIEW; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; GENE EXPRESSION; GENE LIBRARY; METABOLISM; MOLECULAR LIBRARY; PROTEIN ANALYSIS; SYNTHESIS;

CELL LINE; CYCLIZATION; DRUG DISCOVERY; GENE EXPRESSION; GENE LIBRARY; HUMANS; INSULYSIN; MACROCYCLIC COMPOUNDS; MODELS, MOLECULAR; PEPTIDES, CYCLIC; PEPTIDOMIMETICS; PROTEIN INTERACTION MAPPING; SMALL MOLECULE LIBRARIES;

EID: 84923101590     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2015.02.004     Document Type: Review

References (48)

1. Wells J.A., McClendon C.I. Reaching for the high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450:1001-1009.
2. Arkin M.R., Wells J.A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev 2004, 3:301-317.
3. Marsault E., Peterson M.L. Macrocycles are great cycles: applications, opportunities and challenges of synthetic macrocycles in drug discovery. J Med Chem 2011, 54:1961-2004.
4. Driggers E.M., Hale S.P., Lee J., Terrett N.K. The exploration of macrocycles for drug discovery - an underexploited structural class. Nat Rev 2008, 7:608-624.
5. Giordanetto F., Kihlberg J. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties. J Med Chem 2014, 57:278-295.
6. Butler M.S. Natural products to drugs: natural products derived compounds in clinical trials. Nat Prod Rep 2005, 22:162-195.
7. Vagner J., Qu H., Hruby V.J. Peptidomimetics, a synthetic tool of drug discovery. Curr Opin Chem Biol 2008, 12:292-296.
8. White C.J., Yudin A.K. Contemporary strategies for peptide macrocyclization. Nat Chem 2011, 3:509-524.
9. Brownlees C.H., Williams J. Peptidases, peptides, and the mammalian blood-brain barrier. J Neurochem 1993, 60:793-803.
10. Fauchère J.L., Thuriau C. Evaluation of the stability of peptides and pseudopeptides as a tool in peptide drug design. Adv Drug Res 1992, 23:127-159.
11. Woodley J.F. Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst 1994, 11:61-95.
12. Mallinson J., Collins I. Macrocycles in new drug discovery. Future Med Chem 2012, 4:1409-1438.
13. Bockus A.T., McEwen C.M., Lokey R.S. Form and function in cyclic peptide natural products: a pharmacokinetic perspective. Curr Top Med Chem 2013, 13:821-836.
14. Furka A., Sebestyen F., Asgedom M., Dibo G. General method for rapid synthesis of multicomponent peptide mixtures. Int J Pept Protein Res 1991, 37:487-493.
15. Church G.M. Genomes for all. Sci Am 2006, 294:46-54.
16. Hale S.P. Screening large compound collections. A Handbook for DNA-Encoded Chemistry 2014, 281-317. John Wiley & Sons, Inc. R.A. Goodnow (Ed.).
17. Brenner S., Lerner R.A. Encoded combinatorial chemistry. Proc Natl Acad Sci U S A 1992, 89:5381-5383.
18. Nielsen J., Brenner S., Janda K.D. Synthetic methods for the implementation of encoded combinatorial chemistry. J Am Chem Soc 1993, 115:9812-9813.
19. Clark M.A., Acharya R.A., Arico-Muendel C.C., Belyanskaya S.L., Benjamin D.R., Carlson N.R., Centrella P.A., Chiu C.H., Creaser S.P., Cuozzo J.W., et al. Design, synthesis and selection of DNA-encoded small-molecule libraries. Nat Chem Biol 2009, 5:647-654.
20. Hansen M.H., Blakskjaer P., Petersen L.K., Hansen T.H., Højfeldt J.W., Gothelf K.V., Hansen N.J.V. A yoctoliter-scale DNA reactor for small-molecule evolution. J Am Chem Soc 2009, 131:1322-1327.
21. Lundorf FT, Dybro, M, Jacobsen SN, Olsen EK, Andersen AL, Holtmann A, Hansen AH, Sorensen AM, Goldbech A, De Leon D et al.: Oligonucleotide- and ligase-based enzymatic encoding methods for efficient synthesis of large libraries. 2007, US Patent Application WO 2007062664.
22. Gartner Z.J., Liu D.R. The generality of DNA-templated synthesis as a basis for evolving non-natural small molecules. J Am Chem Soc 2001, 123:6961-6963.
23. Gartner Z.J., Kanan M.W., Liu D.R. Multistep small-molecule synthesis programmed by DNA templates. J Am Chem Soc 2002, 124:10304-10306.
24. Gartner Z.J., Tse B.N., Grubina R., Doyon J.B., Snyder T.M., Liu D.R. DNA-templated organic synthesis and selection of a library of macrocycles. Science 2004, 305:1601-1605.
25. Kleiner R.E., Dumelin C.E., Tiu G.C., Sakurai K., Liu D.R. In vitro selection of a DNA-templated small-molecule library reveals a class of macrocyclic kinase inhibitors. J Am Chem Soc 2010, 132:11779-11791.
26. Georghiou G., Kleiner R.E., Pulkoski-Gross M., Liu D.R. Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles. Nat Chem Biol 2012, 8:366-374.
27. Melkko S., Scheuermann J., Dumelin C.E., Neri D. Encoded self-assembling chemical libraries. Nat Biotechnol 2004, 22:568-574.
28. Wei Y., Fan T., Yu M. Inhibitor of apoptosis proteins and apoptosis. Acta Biochem Biophys Sin 2008, 40:278-288.
29. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
30. Wilkinson J.C., Cepero E., Boise L.H., Duckett C.S. Upstream regulatory role for XIAP in receptor-mediated apoptosis. Mol Cell Biol 2004, 24:7003-7014.
31. Chang H.Y., Yang X. Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev 2000, 64:821-846.
32. Deveraux Q.L., Reed J.C. IAP family proteins-suppressors of apoptosis. Genes Dev 1999, 13:239-252.
33. Liu Z., Sun C., Olejniczak E.T., Meadows R.P., Betz S.F., Oost T., Hermann J., Wu J.C., Fesik S.W. Structural basis for binding of Smac/DIABLO to the XIAP BIR 3 domain. Nature 2000, 408:1004-1008.
34. Srinivasula S.M., Ashwell J.D. IAPs: what's in a name?. Mol Cell 2008, 30:123-135.
35. Sun H., Nikolovska-Coleska Z., Lu J., Meagher J.L., Yang C.Y., Qiu S., Tomita Y., Ueda Y., Jiang S., Krajewski K., et al. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP. J Am Chem Soc 2007, 129:15279-15294.
36. Nikolovska-Coleska Z., Meagher J.L., Jiang S., Yang C.Y., Qiu S., Roller P.P., Stuckey J.A., Wang S. Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein. Biochemistry 2008, 47:9811-9824.
37. Sun H., Liu L., Lu J., Qiu S., Yang C.Y., Yi H., Wang S. Cyclopeptide Smac mimetics as antagonists of IAP proteins. Bioorg Med Chem Lett 2010, 20:3043-3046.
38. Song X., Qian Y. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases. Cell Signal 2013, 25:2335-2347.
39. Tse M.T. IL-17 antibodies gain momentum. Nat Rev 2013, 12:815-816.
40. Maianti J.P., McFedries A., Foda Z.H., Kleiner R.E., Du X.Q., Leissring M.A., Tang W.J., Charron M.J., Seeliger M.A., Saghatelian A., Liu D.R. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature 2014, 511:94-98.
41. Tse B.N., Snyder T.M., Shen Y., Liu D.R. Translation of DNA into a library of 13,000 synthetic small-molecule macrocycles suitable for in vitro selection. J Am Chem Soc 2008, 130:15611-15626.
42. Duckworth W.C., Bennett R.G., Hamel F.G. Insulin degradation: progress and potential. Endocr Rev 1998, 19:608-624.
43. Mirsky I.A., Broh-Kahn R.H. The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts. Arch Biochem 1949, 20:1-9.
44. Malito E., Hulse R.E., Tang W.J. Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin. Cell Mol Life Sci 2008, 65:2574-2585.
45. Ahren B., Winzell M.S., Pacini G. The augmenting effect on insulin secretion by oral versus intravenous glucose is exaggerated by high-fat diet in mice. J Endocrinol 2008, 197:181-187.
46. Winzell M.S., Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004, 53:S215-S219.
47. Josephson K., Ricardo A., Szostak J.W. mRNA display: from basic principles to macrocycle drug discovery. Drug Discov Today 2014, 4:388-399.
48. O'Connor C.J., Beckmann H.S.G., Spring D.R. Diversity-oriented synthesis: producing chemical tools for dissecting biology. Chem Soc Rev 2012, 41:4444-4456.